SecBot SecBot
SECBOTREPLAY Home › Report › NBIX

NBIX · Three C-suite officers at Neurocrine Biosciences sold a total of…

NEUROCRINE BIOSCIENCES INC · CLUSTER filed Jun 2, 2026 at 18:08 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Jun 2, 2026 at 18:08 ET

Three C-suite officers at Neurocrine Biosciences sold a total of ~$2.73M in open-market shares within a 7-day window. All sales followed derivative exercises (non-cash M and A), and one officer (Boyer D.) sold without a prior M, which is routine compensation-driven selling. At $16.6B market cap, the cluster is ~0.016% of cap, below the 0.1% materiality floor for insider sales, rendering the cluster classificationally trivial. Per the asymmetry rule for sales (Alldredge 2019), no amplification is applied.

  • Cluster: 3 C-suite officers sold ~2.73M in open-market shares over 7 days (May 26, June 2, 2026)
  • Largest sale: CSO Onyia Jude sold $1.76M (11K shares at ~$160.25) after exercising options
  • CRO Delaet Ingrid sold $354K; Chief Corp. Affairs Boyer D.W. sold $609K; CMO Keswani had only non-cash derivative activity
  • Total open-market sales: ~$2.73M, or ~0.016% of $16.6B market cap, below the 0.1% materiality floor

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access